Notícias e Atividades da Verrica Pharmaceuticals

Verrica Pharmaceuticals é uma empresa listada sob o símbolo VRCA (US).

Veja o organograma con seus 15 executivos principais

Biografias mais buscadas da Verrica Pharmaceuticals

• Jayson Rieger, Chief Executive Officer
• Lawrence Eichenfield, Director
• Sean Stalfort, Director

Recentes movimentos de executivos em Verrica Pharmaceuticals

• Chris Chapman, ingressou na Companhia como Chief Commercial Officer  (Notícia publicada em 12 de fevereiro de 2026).

Criar um alerta
para seguir os movimentos de executivos da Verrica Pharmaceuticals.

Verrica Pharmaceuticals possui 1.913 concorrentes concorrentes Sanofi (França), Eli Lilly (Estados Unidos) e Moderna (Estados Unidos).

Popular M&A news in Farmacêutica

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (publicado em 4 de junho de 2026).
• Contraline acaba de anunciar uma arrecadação de fundos de 93 milhões de dólares. (publicado em 3 de junho de 2026).
• Hims & Hers adquiriu Eucalyptus (publicado em 2 de junho de 2026).

Outros contatos sugeridos na indústria do Farmacêutica

• Joaquin Duato - Chief Executive Officer and Chairman of the Board da Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board da Abbott
• Jonathan Leff - Director da Larimar Therapeutics

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Verrica Pharmaceuticals

• Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan - Verrica Pharmaceuticals
• Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Verrica Pharmaceuticals
• Verrica Provides Business and Operational Update - Verrica Pharmaceuticals
• Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan - Verrica Pharmaceuticals
• Verrica Announces Pricing of $42.0 Million Public Offering - Verrica Pharmaceuticals
• Press Releases - Verrica Pharmaceuticals
• Verrica Announces Proposed Public Offering - Verrica Pharmaceuticals
• Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition - Verrica Pharmaceuticals
• Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP 315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference - Verrica Pharmaceuticals
• Verrica Pharmaceuticals Announces Restructuring of Commercial Organization - Verrica Pharmaceuticals
• View more press releases Close

Redes sociais sobre Verrica Pharmaceuticals

• Verrica Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Verrica Pharmaceuticals na LinkedIn, X (Twitter) e YouTube